Common Reasons for “For-Cause” Inspections in Bioequivalence Studies Submitted to the Food and Drug Administration

“For-cause” inspections are initiated during the review of bioequivalence (BE) data submitted to Abbreviated New Drug Applications when possible scientific misconduct and study irregularities are discovered. We investigated the common reasons for initiating “for-cause” inspections related to the cli...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Li, Bing V., Davit, Barbara M., Lee, Christina H., Pabba, Santhosh K., Mahadevan, Chitra, Caramenico, Hoainhon T., Haidar, Sam H, Sanchez, Aida L., Sigler, Aaron W., Stier, Ethan M., Conner, Dale P.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2012
Assuntos:
Regulatory Note
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3535114/
https://ncbi.nlm.nih.gov/pubmed/23054974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12248-012-9415-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados